Showing results (81-90 of 110) with videos related to
Sort By:
Pageof 11
Human Brain Mapping|March 23, 2012
The structural correlates of functional deficits in early huntington's diseaseChristine Delmaire, Eve M Dumas, Michael A Sharman, et al.Neurology. Genetics|June 18, 2020
Genotyping single nucleotide polymorphisms for allele-selective therapy in Huntington diseaseDaniel O Claassen, Jody Corey-Bloom, E Ray Dorsey, et al.Frontiers in Neurology|July 24, 2019
International Guidelines for the Treatment of Huntington's DiseaseAnne-Catherine Bachoud-Lévi, Joaquim Ferreira, Renaud Massart, et al.Journal of Huntington'S Disease|July 27, 2014
Corpus callosal atrophy in premanifest and early Huntington's diseaseHelen E Crawford, Nicola Z Hobbs, Ruth Keogh, et al.The Lancet. Neurology|December 6, 2011
Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational dataSarah J Tabrizi, Ralf Reilmann, Raymund A C Roos, et al.The Lancet. Neurology|December 7, 2010
Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysisSarah J Tabrizi, Rachael I Scahill, Alexandra Durr, et al.Movement Disorders : Official Journal of the Movement Disorder Society|March 23, 2019
A roadmap for implementation of patient-centered digital outcome measures in Parkinson's disease obtained using mobile health technologiesAlberto J Espay, Jeffrey M Hausdorff, Álvaro Sánchez-Ferro, et al.The Lancet. Neurology|January 27, 2024
Safety and efficacy of laquinimod for Huntington's disease (LEGATO-HD): a multicentre, randomised, double-blind, placebo-controlled, phase 2 studyRalf Reilmann, Karen E Anderson, Andrew Feigin, et al.Movement Disorders : Official Journal of the Movement Disorder Society|March 25, 2011
What is the impact of education on Huntington's disease?Jose Luis López-Sendón, Ana Royuela, Patricia Trigo, et al.Nature Reviews. Neurology|March 12, 2014
Huntington disease: natural history, biomarkers and prospects for therapeuticsChristopher A Ross, Elizabeth H Aylward, Edward J Wild, et al.Pageof 11